Bullous pemphigoid is a rare autoimmune disease that affects your skin. It’s a chronic disease that causes itchy, fluid-filled blisters to form all over your body. Although people of all ages, ...
For centuries, bullous pemphigoid (BP) was grouped with and considered a condition similar to pemphigus vulgaris (PV). In 1953, however, Lever recognized BP as a disorder distinct from PV. 9 BP, the ...
Bullous pemphigoid (BP) is an autoimmune disorder that mainly affects older adults. The condition causes your immune system to attack proteins that hold the layers of your skin together. This damages ...
Pemphigoid gestationis is a rare autoimmune skin condition that may develop during pregnancy. It can cause an itchy rash and blisters. However, treatments such as corticosteroids can help. Pemphigoid ...
Please provide your email address to receive an email when new articles are posted on . Sustained disease remission occurred in 20% of the study cohort vs. 4% of the placebo group at week 36. 41% of ...
Bullous pemphigoid, an immune-mediated condition characterized by large, fluid-filled blisters on the skin, is a rare but serious complication of cancer therapy with immune checkpoint inhibitors (ICIs ...
More patients treated with dupilumab experienced sustained disease remission and itch reduction at week 36 compared with those who received placebo. The Food and Drug Administration (FDA) has approved ...
A Prescription Drug User Fee Act target date of June 20, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics ...
Past research shows no meaningfully increased risk of venous thromboembolism (VTE) in patients with more common chronic inflammatory skin diseases. Bullous pemphigoid (BP) is associated with a 2-fold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results